Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback